| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2128 | 2003 |
| Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ... Jama 316 (2), 171-181, 2016 | 1796 | 2016 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1511 | 2006 |
| Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk, AA Monforte, ... Aids 17 (8), 1179-1193, 2003 | 1408 | 2003 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1183 | 2008 |
| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ... The Lancet 384 (9939), 241-248, 2014 | 1154 | 2014 |
| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1125 | 2019 |
| AIDS across Europe, 1994–98: the EuroSIDA study A Mocroft, C Katlama, AM Johnson, C Pradier, F Antunes, F Mulcahy, ... The Lancet 356 (9226), 291-296, 2000 | 642 | 2000 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 458 | 2010 |
| Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? E Fontas, F Van Leth, CA Sabin, N Friis-Møller, M Rickenbach, ... The Journal of infectious diseases 189 (6), 1056-1074, 2004 | 428 | 2004 |
| The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D: A: D study MG Law, N Friis‐Møller, WM El‐Sadr, R Weber, P Reiss, ... HIV medicine 7 (4), 218-230, 2006 | 388 | 2006 |
| Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ... The Journal of infectious diseases 207 (9), 1359-1369, 2013 | 376 | 2013 |
| Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) E Rosenthal, M Poiree, C Pradier, C Perronne, D Salmon-Ceron, ... Aids 17 (12), 1803-1809, 2003 | 355 | 2003 |
| HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies A d'Arminio Monforte, D Abrams, C Pradier, R Weber, P Reiss, F Bonnet, ... Aids 22 (16), 2143-2153, 2008 | 334 | 2008 |
| High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy A Tran, JF Quaranta, S Benzaken, V Thiers, HT Chau, P Hastier, ... Hepatology 18 (2), 253-257, 1993 | 305 | 1993 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 293 | 2005 |
| Discontinuation of Secondary Prophylaxis against Pneumocystis carinii Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy B Ledergerber, A Mocroft, P Reiss, H Furrer, O Kirk, M Bickel, ... New England Journal of Medicine 344 (3), 168-174, 2001 | 239 | 2001 |
| Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study* K Petoumenos, S Worm, P Reiss, S De Wit, A d'Arminio Monforte, C Sabin, ... HIV medicine 12 (7), 412-421, 2011 | 213 | 2011 |
| Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor S Grabar, C Pradier, E Le Corfec, R Lancar, C Allavena, M Bentata, ... Aids 14 (2), 141-149, 2000 | 196 | 2000 |
| Epidemiology of bacterial infection during management of open leg fractures H Carsenti-Etesse, F Doyon, N Desplaces, O Gagey, C Tancrede, ... European Journal of Clinical Microbiology and Infectious Diseases 18, 315-323, 1999 | 194 | 1999 |
